Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Endocrine Regulations
Volume 56 (2022): Issue 4 (October 2022)
Open Access
Prolactinoma - which patients react favorably to cabergoline medication?
Savas Karatas
Savas Karatas
Endocrinology and Metabolism Department, Istanbul Research and Education Hospital
Istanbul, Turkey
Search for this author on
Sciendo
|
Google Scholar
Karatas, Savas
,
Yalcin Hacioglu
Yalcin Hacioglu
Family Medicine Department, Istanbul Research and Education Hospital
Istanbul, Turkey
Search for this author on
Sciendo
|
Google Scholar
Hacioglu, Yalcin
and
Taskin Rakicioglu
Taskin Rakicioglu
Radiology Department, Istanbul Research and Education Hospital
Istanbul, Turkey
Search for this author on
Sciendo
|
Google Scholar
Rakicioglu, Taskin
Oct 20, 2022
Endocrine Regulations
Volume 56 (2022): Issue 4 (October 2022)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Published Online:
Oct 20, 2022
Page range:
279 - 283
DOI:
https://doi.org/10.2478/enr-2022-0030
Keywords
prolactinoma
,
pituitary
,
endocrinology
© 2022 Savas Karatas et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
